instruction
stringclasses 1
value | input
stringlengths 53
318
| output
stringlengths 4
72
⌀ |
|---|---|---|
Identify mentioned drugs from the abstract title | Baseline GP2 immune response as an independent prognostic factor in a phase IIb study evaluating HER2/neu peptide GP2 (GLSI-100) versus. GM-CSF alone after adjuvant trastuzumab in HER2-positive women with breast cancer. | GLSI-100;;GM-CSF |
Identify mentioned drugs from the abstract title | Development of radiolabelled plerixafor as a theranostic tool for malignant lymphomas | Plerixafor |
Identify mentioned drugs from the abstract title | 12-year trend in utilization of IVIG and plasmapheresis following acute myasthenia exacerbation and myasthenic crisis in the United States and their association with outcome. | IVIG |
Identify mentioned drugs from the abstract title | Deep Immune Profiling in Multiple Myeloma at Diagnosis and Under Lenalidomide Maintenance Therapy | Lenalidomide |
Identify mentioned drugs from the abstract title | Anlotinib plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: A prospective, single-arm, single-center, phase II clinical study. | anlotinib |
Identify mentioned drugs from the abstract title | Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine | Deutetrabenazine |
Identify mentioned drugs from the abstract title | Apatinib Combined With Irinotecan in the Treatment of Small Cell Lung Cancer: A Phase 2, Single-Arm, Prospective Study | Apatinib;;Irinotecan |
Identify mentioned drugs from the abstract title | CISH gene-knockout anti-CD70-CAR NK cells demonstrate potent anti-tumor activity against solid tumor cell lines and provide partial resistance to tumor microenvironment inhibition | Anti-CD70-CAR NK Cell |
Identify mentioned drugs from the abstract title | A Retrospective Comparison of Survival Outcomes in EGFR-mutated, NSCLC Patients on Osimertinib +/- Brain Metastases | Osimertinib |
Identify mentioned drugs from the abstract title | Cisplatin versus mitomycin plus fluoropyrimidine and radiation for localized squamous cell carcinoma of the anus (SCCA) - final results of GTG-LACOG 1318 real world data study | Cisplatin;;Mitomycin |
Identify mentioned drugs from the abstract title | CCRL2 affects the sensitivity of MDS and secondary AML to azacitidine | Azacitidine |
Identify mentioned drugs from the abstract title | A Study of ALPN-202, a PD-L1-dependent CD28 costimulator and dual checkpoint inhibitor, in combination with pembrolizumab in patients with advanced malignancies | ALPN-202;;Pembrolizumab |
Identify mentioned drugs from the abstract title | A common gut commensal utilizes tryptophan to promote cancer via the aryl hydrocarbon receptor | Tryptophan |
Identify mentioned drugs from the abstract title | Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen. | Oxaliplatin |
Identify mentioned drugs from the abstract title | Brentuximab Vedotin Plus ESHAP (BRESHAP) Versus ESHAP As Salvage Strategy for Patients with Primary Refractory or Relapsed Classical Hodgkin's Lymphoma. Preliminary Results from the Breselibet Prospective Clinical Trial | Brentuximab Vedotin;;ESHAP;;ESHAP |
Identify mentioned drugs from the abstract title | A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer. | Lenvatinib |
Identify mentioned drugs from the abstract title | A WT1 oral cancer vaccine using a Bifidobactrerium vector suppresses growth of anti-PD-1 antibody-resistant mouse bladder tumor | WT1 Cancer Vaccine |
Identify mentioned drugs from the abstract title | 3-year update of neoadjuvant atezolizumab + chemotherapy in patients with resectable non-small cell lung cancer | Atezolizumab |
Identify mentioned drugs from the abstract title | Degree Of Cell Packing Of Cryopreserved At -80oC Hematopoietic Stem Cells Does Not Affect Their Viability And Hematologic Recovery Of Transplanted Myeloma Patients | Hematopoietic Stem Cell |
Identify mentioned drugs from the abstract title | CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancerand PSMA-positive disease (NCT04663997). | [177-Lu]Lu-PSMA-617;;Docetaxel |
Identify mentioned drugs from the abstract title | A Phase 1, First in Human (FIH) study of autologous macrophages containing an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors. | Anti-HER2 CAR Macrophage |
Identify mentioned drugs from the abstract title | CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616 | Ipilimumab;;Nivolumab |
Identify mentioned drugs from the abstract title | Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd) | Carfilzomib;;Dexamethasone;;Elotuzumab;;Lenalidomide |
Identify mentioned drugs from the abstract title | Biomarkers of Clinical Resistance to Decitabine and Venetoclax Therapy Inferred By Transcriptome and Methylation Analyses | Decitabine;;Venetoclax |
Identify mentioned drugs from the abstract title | Beyond PACIFIC: Real-world outcomes of adjuvant durvalumab according to treatment received and PD-L1 expression | Durvalumab |
Identify mentioned drugs from the abstract title | Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party | Fludarabine;;Melphalan;;Thiotepa;;BCNA;;Fludarabine;;Melphalan;;Thiotepa |
Identify mentioned drugs from the abstract title | ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis. | Abiraterone Acetate |
Identify mentioned drugs from the abstract title | Updates on Abstract 388570: Landscape of Pathogenic Germline Variants in Patients with Lung Cancer. | null |
Identify mentioned drugs from the abstract title | A switch in mechanism of action attenuates doxorubicin-mediated cardiotoxicity | Doxorubicin |
Identify mentioned drugs from the abstract title | Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer: Results from the IPSOC-mamma study | Everolimus;;Exemestane |
Identify mentioned drugs from the abstract title | Cannabidiol in anxiety research – a translational integration of preclinical and clinical studies | Cannabidiol |
Identify mentioned drugs from the abstract title | Delay of Aspirin Administration in patients after Stroke Code Activation, who are not candidates for tissue Plasminogen Activator (t-PA) or Mechanical Thrombectomy (MT) pre- and post-COVID pandemic. | Aspirin |
Identify mentioned drugs from the abstract title | A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) | NIVO;;Nivolumab |
Identify mentioned drugs from the abstract title | Desmopressin is twice effective in females: A systematic review and meta-analysis on medical treatment of nocturia | Desmopressin |
Identify mentioned drugs from the abstract title | Clinical and microbiological outcomes for Enterobacterales uropathogens in the Phase 3 ADAPT-PO Study of oral tebipenem pivoxil hydrobromide | Tebipenem Pivoxil Hydrobromide |
Identify mentioned drugs from the abstract title | A randomized, pre-surgical study to investigate the biological effects of AZD9833 doses in women with ER-positive HER2-negative primary breast cancer (SERENA-3) | AZD-9833 |
Identify mentioned drugs from the abstract title | Bms-986158, A Potent Bet Inhibitor, As Monotherapy And In Combination With Ruxolitinib Or Fedratinib In Intermediate- Or High-Risk Myelofibrosis (Mf): Results From A Phase 1/2 Study | BMS-986158;;Fedratinib;;Ruxolitinib |
Identify mentioned drugs from the abstract title | ASTX660, a non-peptidomimetic antagonist of cIAP1/2 and XIAP, enhances immune mediated tumor killing and induction of immunogenic cell death | ASTX-660 |
Identify mentioned drugs from the abstract title | ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors. | Nemvaleukin Alfa;;Pembrolizumab |
Identify mentioned drugs from the abstract title | BATF3/MYC axis drives hyper-proliferation of TET2 deficient CAR T cells | CAR T-cell |
Identify mentioned drugs from the abstract title | Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of Phase 3 Atalante-1 randomised trial | OSE-2101 |
Identify mentioned drugs from the abstract title | A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the PiggyBac Transposon Vector for Acute Lymphoblastic Leukemia | CD19 CAR T-Cell |
Identify mentioned drugs from the abstract title | An Open-Label, Multicenter, Phase 1/2 Clinical Trial of RP1 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors [IGNYTE] | RP1;;Nivolumab |
Identify mentioned drugs from the abstract title | Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients. | Ipilimumab;;Nivolumab |
Identify mentioned drugs from the abstract title | A Phase 1B/2 Study Of Tp-0903 And Decitabine Targeting Mutant Tp53 And/Or Complex Karyotype In Patients With Untreated Acute Myeloid Leukemia (Aml) >= Age 60 Years: Final Results | Decitabine;;TP-0903 |
Identify mentioned drugs from the abstract title | D3L-001, a novel bispecific antibody targeting HER2 and CD47, demonstrates potent preclinical efficacy in solid tumors. | D3L-001 |
Identify mentioned drugs from the abstract title | Chemotherapy and bevacizumab prescription in routine management of metastatic colorectal cancer in Uruguay: Is clinical practice following the evidence? | Bevacizumab |
Identify mentioned drugs from the abstract title | Allo-Hct In Myelofibrosis - Current And Future Trends | ALLO |
Identify mentioned drugs from the abstract title | A functional approach to identifying and engineering TCRs results in highly-potent and specific TCRs for TCR-T cell therapy | TCR-T Cell |
Identify mentioned drugs from the abstract title | The Role Of Treatment Strategy In Reducing The Disability Risk In Multiple Sclerosis | null |
Identify mentioned drugs from the abstract title | 68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients | 68Ga-PSMA |
Identify mentioned drugs from the abstract title | CRISPR/Cas9 gene-edited, allogeneic anti-CD83 CAR-T cells demonstrate potent activity in GvHD and AML tumor models | Anti-CD83 CAR-T Cell |
Identify mentioned drugs from the abstract title | Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: A multicenter, multicohort clinical trial (ALTER-G-001). | Anlotinib |